Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp. (PHIO) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
phio · stock forecast · 2 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 2 Wall Street analysts in the past 3 months
Buy
2 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $1.09
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $1.09 | ↑ 0.25% |
1-day model range: $1.08–$1.11. Peak: $1.11 (+0.25%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | -50.0% |
| 2028 | — | -62.5% |
| 2029 | — | -67.2% |
| 2030 | — | -69.2% |
| 2031 | — | -70.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · PHIO · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-02-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-06-25 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-04-08 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-02-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-05-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-02-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-08-16 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2021-06-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2020-11-25 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Phio Pharmaceuticals Corp. (PHIO) stock. Of the recent 12 rating actions, 0 were upgrades and 0 were downgrades. 2 analysts currently cover PHIO.
Analyst Recommendation Trends
PHIO analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$75M
↑ 0.0% YoY
Revenue Next Year
$50M
↓ 33.3% YoY
EPS This Year
$-56.34
EPS Next Year
$-8.54
↓ 84.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast PHIO EPS of $-56.34 for the current fiscal year, based on estimates from 1 analysts. The PHIO revenue forecast is $75M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The PHIO stock forecast is supported by two independent data sources: analyst consensus ratings from 2 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus PHIO price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
The PHIO short-term stock prediction for tomorrow is $1.09 (+0.25%). The PHIO stock prediction for 2030 projects a range of $0–$0.
Phio Pharmaceuticals Corp. trades on NASDAQ under the ticker PHIO. The PHIO stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
PHIO forecast · 8 questionsAccording to 2 Wall Street analysts, the average 12-month PHIO price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $1.09.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.